Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about NOVARTIS AG
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/25NOVARTIS AG : Bryan Garnier maintains a Buy rating
MD
11/25NOVARTIS AG : UBS reiterates its Buy rating
MD
11/25NOVARTIS AG : Goldman Sachs remains its Buy rating
MD
11/24NOVARTIS AG : Goldman Sachs reaffirms its Buy rating
MD
11/24NOVARTIS : to Repurchase Up to $2.5 Billion in Shares
DJ
11/24NOVARTIS : starts share buyback, highlights product pipeline
RE
11/24NOVARTIS : highlights confidence in growing sales with margin expansion, fueled ..
AQ
11/20NOVARTIS : New data at ASH to reinforce breadth of Novartis hematology portfolio..
AQ
11/19NOVARTIS : and Enel X present at ANCI 2020 the study on the relationship between..
AQ
11/19NOVARTIS : Signs Five Contracts as Part of Green Energy Push
DJ
11/16NOVARTIS : Results from real-world data and post-hoc analysis of Novartis Beovu ..
AQ
11/13NOVARTIS : Results from real-world data and post-hoc analysis of Novartis Beovu®..
PU
11/12NOVARTIS CASE : Is Rebranding Generic Medicine To The Originator Brand Name Allo..
AQ
11/11NOVARTIS : Capital Increase in Genmab as a Result of Employee Warrant Exercise
AQ
More most relevant news
All news about NOVARTIS AG
11/26Business rights or human rights? Swiss vote shines spotlight on companies
RE
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/25NOVARTIS AG : Bryan Garnier maintains a Buy rating
MD
11/25NOVARTIS AG : UBS reiterates its Buy rating
MD
11/25NOVARTIS AG : Goldman Sachs remains its Buy rating
MD
11/24GLOBAL MARKETS LIVE: Tesla, Best Buy, Qantas…
11/24NOVARTIS AG : Goldman Sachs reaffirms its Buy rating
MD
11/24NOVARTIS : to Repurchase Up to $2.5 Billion in Shares
DJ
11/24NOVARTIS : starts share buyback, highlights product pipeline
RE
11/24NOVARTIS : highlights confidence in growing sales with margin expansion, fueled ..
AQ
More news
News in other languages on NOVARTIS AG
11/26Bourse Zurich: le SMI finit juste sous la barre des 10'500 points, dans le ve..
11/26Aktien Schweiz bewegen sich weiter seitwärts
11/26Aktien Schweiz: SMI verteidigt leichtes Plus
11/26Bourse Zurich: l'optimisme se maintient en fin de matinée
11/25Aktien Schweiz Schluss: SMI schliesst wenig verändert
11/25Bourse Zurich: le SMI finit juste dans le rouge sous la barre des 10'500 poin..
11/25NOVARTIS AG : Bryan Garnier favorable sur le dossier
11/25Bryan Garnier hebt Ziel für Novartis auf 115 Franken - 'Buy'
11/25NOVARTIS AG : UBS toujours positif
11/25UBS hebt Ziel für Novartis auf 99 Franken - 'Buy'
Analyst Recommendations on NOVARTIS AG
11/25NOVARTIS AG : Bryan Garnier maintains a Buy rating
MD
11/25NOVARTIS AG : UBS reiterates its Buy rating
MD
11/25NOVARTIS AG : Goldman Sachs remains its Buy rating
MD
11/24NOVARTIS AG : Goldman Sachs reaffirms its Buy rating
MD
11/10NOVARTIS AG : JP Morgan reiterates its Sell rating
MD
More recommendations
Press releases
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24NOVARTIS : highlights confidence in growing sales with margin expansion, fueled ..
AQ
11/20NOVARTIS : New data at ASH to reinforce breadth of Novartis hematology portfolio..
AQ
11/20Pfizer suffers setback in ENBREL battle of patent infringement claim
AQ
11/19NOVARTIS : and Enel X present at ANCI 2020 the study on the relationship between..
AQ
More press releases